BioPhorum
Connect
||
Collaborate
||
Accelerate

Since its inception in 2004, BioPhorum has become the open and trusted environment where senior leaders of the biopharmaceutical industry come together to openly share and discuss the emerging trends and challenges facing their industry.

Growing from an end-user group in 2008, BioPhorum now comprises over 120 manufacturers and suppliers deploying their top 5000 leaders and subject matter experts to work in eight focused Phorums, articulating the industry’s technology roadmap, defining the supply partner practices of the future, and developing and adopting best practices in drug substance, fill finish, process development and manufacturing IT.

BioPhorum Guided Facailitation InfoGraphic

Newsletter subscribe

Enter your E-mail address to receive our monthly newsletter direct to your inbox.

This field is for validation purposes and should be left unchanged.

You can unsubscribe at any time to clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

Recent releases

biophorum post images website images october2 (1) 169
Oct 04 2021

Seven practices to ensure your patching program is a success

Manufacturing companies are increasingly investing in routine patching or patch management to improve their response to cyberattacks.  However,...
biophorum post images website images october3 165
Oct 01 2021

MedTech celebrates its first year anniversary with new program additions

One year ago, a group of stakeholders from several BioPhorum members came together to define a program of work...
biophorum post images website images october4 167
Oct 01 2021

The Spontaneous Infection: Did you leave the back door to your cultivation suite open?

In Shared clean-in-place systems: To share or not to share? and How much harm can a single droplet do? Considerations for a viral inactivation step, BioPhorum’s Drug...
biophorum post images website images october 166
Oct 01 2021

Steps to eradicate undetected contaminations in anaerobic testing

All biopharmaceutical manufacturers have a legal obligation to monitor the microorganisms that are found in their plant. Regulations require that the...
biophorum post images website graphics cgt september special 160
Sep 20 2021

Using a matrix approach to address challenges for potency assay development for in vivo and ex vivo gene therapies.

The gene therapy field is advancing rapidly and though there has been significant progress, there are yet relatively few commercial products approved globally...
biophorum post images website graphics cgt september special4 158
Sep 20 2021

RNA: new CGT workstream to focus on this industry priority

When planning the 2021 BioPhorum Cell & Gene Therapy program, senior member representatives indicated that they wanted a new workstream focusing on what they...

A powerful vehicle for change

BioPhorum facilitators bring leaders together to create future visions, mobilize teams of experts on the opportunities, create partnerships that enable change and provide the quickest route to implementation, so that the industry shares, learns and builds the best solutions together.

LONG READ

Chain reaction: how the biopharmaceutical supply chain survived the pandemic

Read more

Our mission

Bringing leaders together

to create future visions that focus the industry’s energy on the key emerging opportunities

Mobilizing communities

of the top experts around these opportunities, up and down the biopharma value chain

Creating partnerships

that enable change and provide the quickest route to implementation and results

Replacing isolation

with collaboration so that the industry shares, learns and
builds the best solutions togethe

Work with us

BioPhorum is a global collaboration of industry leaders and subject matter experts working together to pool knowledge, practices, and ideas, which lead to results that effect real change.